UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Cuts Holdings in Privia Health Group, Inc. $PRVA

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lessened its position in shares of Privia Health Group, Inc. (NASDAQ:PRVA) by 5.1% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,948,021 shares of the company’s stock after selling 103,638 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned about 1.53% of Privia Health Group worth $50,123,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. GAMMA Investing LLC increased its position in shares of Privia Health Group by 14.0% during the 2nd quarter. GAMMA Investing LLC now owns 4,819 shares of the company’s stock valued at $124,000 after purchasing an additional 592 shares during the last quarter. PNC Financial Services Group Inc. lifted its holdings in Privia Health Group by 8.8% during the 1st quarter. PNC Financial Services Group Inc. now owns 10,361 shares of the company’s stock valued at $213,000 after buying an additional 840 shares in the last quarter. ProShare Advisors LLC increased its position in shares of Privia Health Group by 4.1% during the fourth quarter. ProShare Advisors LLC now owns 22,576 shares of the company’s stock worth $535,000 after acquiring an additional 898 shares during the period. Vanguard Personalized Indexing Management LLC increased its holdings in Privia Health Group by 5.9% during the 4th quarter. Vanguard Personalized Indexing Management LLC now owns 16,250 shares of the company’s stock worth $385,000 after purchasing an additional 903 shares during the period. Finally, Hantz Financial Services Inc. increased its stake in shares of Privia Health Group by 456.2% during the fourth quarter. Hantz Financial Services Inc. now owns 1,129 shares of the company’s stock valued at $27,000 after buying an additional 926 shares during the period. 94.48% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

PRVA has been the topic of several research reports. Citigroup reissued a “buy” rating on shares of Privia Health Group in a report on Thursday, July 23rd. Canaccord Genuity Group set a $32.00 price objective on shares of Privia Health Group in a report on Friday, August 7th. Zacks Research upgraded Privia Health Group from a “strong sell” rating to a “hold” rating in a research note on Wednesday, August 5th. Barclays reduced their price target on shares of Privia Health Group from $25.00 to $24.00 and set an “equal weight” rating for the company in a research report on Tuesday, May 26th. Finally, Weiss Ratings upgraded Privia Health Group from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, July 2nd. Eleven investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $31.00.

Privia Health Group Stock Up 0.4%

PRVA opened at $20.72 on Thursday. The company has a 50-day moving average price of $24.14 and a 200 day moving average price of $23.17. The company has a market cap of $2.65 billion, a PE ratio of 98.67, a price-to-earnings-growth ratio of 1.63 and a beta of 0.87. Privia Health Group, Inc. has a twelve month low of $19.53 and a twelve month high of $28.82.

Privia Health Group (NASDAQ:PRVA) last announced its earnings results on Thursday, August 6th. The company reported $0.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.07 by $0.12. The company had revenue of $632.63 million for the quarter, compared to analysts’ expectations of $597.33 million. Privia Health Group had a net margin of 1.19% and a return on equity of 3.52%. The firm’s quarterly revenue was up 21.4% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.24 EPS. As a group, sell-side analysts expect that Privia Health Group, Inc. will post 0.27 earnings per share for the current year.

Insider Buying and Selling

In other Privia Health Group news, Director Matthew Shawn Morris sold 53,722 shares of Privia Health Group stock in a transaction dated Monday, July 6th. The stock was sold at an average price of $27.24, for a total value of $1,463,387.28. Following the completion of the transaction, the director directly owned 68,188 shares of the company’s stock, valued at $1,857,441.12. The trade was a 44.07% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO David Mountcastle sold 21,275 shares of Privia Health Group stock in a transaction that occurred on Thursday, July 9th. The shares were sold at an average price of $27.67, for a total transaction of $588,679.25. Following the completion of the transaction, the chief financial officer owned 164,853 shares of the company’s stock, valued at $4,561,482.51. This trade represents a 11.43% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 327,886 shares of company stock worth $8,628,256 over the last three months. Insiders own 5.70% of the company’s stock.

About Privia Health Group

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.